A UC Davis Health study reveals persistent racial and social disparities preventing access to autoHCT, a common bone marrow transplant treatment to halt the progression of multiple myeloma.
Apr 23, 2024
0
0
As someone who started marathon running in midlife, I know how many aches and pains (and doubts) you can have if you take on the challenge to start running at an older age. But as an orthopedic surgeon who has replaced thousands ...
Apr 22, 2024
0
2
An immune-compromised man with a year-and-a-half-long COVID infection served as a breeding ground for dozens of coronavirus mutations, a new study discovered.
Apr 19, 2024
0
37
In recent years, a growing body of research has shown that the human body can "remember" the pain of newborn injuries—including life-saving surgeries—all the way into adolescence.
Apr 18, 2024
0
127
In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of ...
Apr 18, 2024
0
18
Scientists have found a potential treatment strategy for an aggressive type of leukemia by targeting enzymes used by cells to sense and adapt to oxygen levels.
Apr 18, 2024
0
37
Severe sepsis from bacterial or viral infections can be life-threatening and even people recovering from severe sepsis may experience long-lasting effects on the immune system, making them more susceptible to recurrent infections. ...
Apr 11, 2024
0
49
A new research paper titled "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia" has been published in Oncotarget.
Apr 10, 2024
0
0
Findings from the largest UK study of patients hospitalized with SARS-CoV-2 infection show that long COVID leads to ongoing inflammation which can be detected in the blood.
Apr 8, 2024
0
183
A key mechanism controlling how bone marrow stem cells work has been revealed in a new study, shining a light on the principles of stem cell biology and opening the door to new therapeutic pathways.
Apr 4, 2024
0
1
